Abstract
The role of genetics in the causation of cerebral palsy has become the focus of many studies aiming to unravel the heterogeneous etiology behind this frequent neurodevelopmental disorder. A recent paper reported two unrelated children with a clinical diagnosis of cerebral palsy, who carried the same de novo c.1000G > A (p.Asp334Asn) variant in FBXO31, encoding a widely studied tumor suppressor not previously implicated in monogenic disease. We now identified a third individual with the recurrent FBXO31 de novo missense variant, featuring a spastic-dystonic phenotype. Our data confirm a link between variant FBXO31 and an autosomal dominant neurodevelopmental disorder characterized by prominent motor dysfunction.
| Dokumententyp: | Zeitschriftenartikel | 
|---|---|
| Fakultät: | Medizin > Munich Cluster for Systems Neurology (SyNergy) | 
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit | 
| URN: | urn:nbn:de:bvb:19-epub-117754-2 | 
| Sprache: | Englisch | 
| Dokumenten ID: | 117754 | 
| Datum der Veröffentlichung auf Open Access LMU: | 07. Jun. 2024 15:52 | 
| Letzte Änderungen: | 11. Jun. 2024 14:11 | 
| DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 390857198 | 
		
	
